Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Antibody Mediated Immunity Against Brucella

$1.94M USD

Funder NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization University of Missouri-Columbia
Country United States
Start Date Jul 25, 2024
End Date Jun 30, 2026
Duration 705 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10950094
Grant Description

Abstract: No vaccines are currently licensed to prevent human brucellosis and existing vaccines for livestock are not entirely efficacious. In humans and other animals, Brucella can cause a lifelong infection. However, mechanisms underlying the ability of Brucella to subvert adaptive immunity remain unclear. In this proposal we show that vaccine elicited antibodies alter host metabolism to

protect the host against Brucella to some degree. Therefore, in Specific Aim #1 of this proposal we will determine how vaccine-elicited IgM and class switched antibodies alter tissue metabolism to restrict Brucella infection. We also found that Brucella encodes virulence factors that mediate evasion of humoral immunity. Therefore, in Specific Aim #2 of this proposal we will identify

mechanisms by which Brucella subverts antibody mediated immunity. Collectively, our results will enhance our understanding of how current vaccines protect the host, and how Brucella is able to subvert adaptive immunity, and thus could improve the rational design of highly effective vaccines for Brucella.

All Grantees

University of Missouri-Columbia

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant